You are searching for: COVID-19

T94549
Target Info
Target Name HUMAN angiopoietin-2 (ANG-2)
Target type Target in Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
Drugs LY3127804 Drug Info
T94912
Target Info
Target Name HUMAN C5a receptor (C5aR)
Target type Target in Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
Drugs Avdoralimab Drug Info
T97747
Target Info
Target Name HUMAN C-C chemokine receptor 5 (CCR5)
Target type Target in Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
Drugs Leronlimab Drug Info
T90070
Target Info
Target Name HUMAN interleukin 8 (IL8)
Target type Target in Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
Drugs BMS-986253 Drug Info
T94119
Target Info
Target Name HUMAN PI3-kinase delta (PIK3CD)
Target type Target in Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
Drugs Duvelisib Drug Info
T94131
Target Info
Target Name HUMAN PI3-kinase gamma (PIK3CG)
Target type Target in Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
Drugs Duvelisib Drug Info
T89083
Target Info
Target Name HUMAN toll-like receptor 2 (TLR2)
Target type Target in Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
Drugs PUL-042 Drug Info
T89415
Target Info
Target Name HUMAN toll-like receptor 6 (TLR6)
Target type Target in Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
Drugs PUL-042 Drug Info
T87633
Target Info
Target Name HUMAN toll-like receptor 9 (TLR9)
Target type Target in Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
Drugs PUL-042 Drug Info
T99685
Target Info
Target Name HUMAN mammalian target of rapamycin (mTOR)
Target type Target in Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19); Middle East Respiratory Syndrome (MERS)
Drugs Sirolimus Drug Info

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.